FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
FDA General

GAO Report Hits FDA on Investigator Retention

A new Government Accountability Office report says FDA needs to evaluate its recruitment and retention efforts to support and maintain its investigato...

latest-news-card-1
Federal Register

Panel to Mull Minimal Residual Disease Endpoint

Federal Register notice: FDA announces a 4/12 Oncologic Drugs Advisory Committee meeting to discuss the use of minimal residual disease as an endpoint...

latest-news-card-1
Human Drugs

Quantitative Medicine Center of Excellence Created

CDER creates a new Center of Excellence for Quantitative Medicine to advance therapeutic medical product development and inform regulatory decision-ma...

latest-news-card-1
Federal Register

4 Information Collections Approved by OMB

FDA posts a notification about four information collections that have been approved by OMB.

latest-news-card-1
Medical Devices

Arrow QuickFlash Radial Artery Catheter Recall

Teleflex/Arrow International recalls the Arrow QuickFlash Radial Artery Catheterization Set (wire, guide, catheter) device due to reports about a pote...

latest-news-card-1
Human Drugs

Italfarmaco Wins Approval for Duchenne Drug

FDA approves Italfarmacos Duvyzat (givinostat), an oral drug for treating Duchenne Muscular Dystrophy in patients six years of age and older.

latest-news-card-1
Federal Register

Debarment Order Against Principal Investigator

Federal Register notice: FDA issues an order to permanently debar Martin Valdes from providing services in any capacity to a person that has an approv...

latest-news-card-1
Human Drugs

FTC Challenges Teva Orange Book Listings

The Federal Trade Commission files an amicus brief calling out Teva Pharmaceuticals for improperly listed patents in FDAs Orange Book.

latest-news-card-1
Human Drugs

Pemgarda Authorized for Preventing Covid

FDA grants Invivyd an emergency use authorization for Pemgarda (pemivibart) and its use for pre-exposure prophylaxis of Covid-19.

latest-news-card-1
Human Drugs

FDA Settles Ivermectin Messaging Lawsuit

FDA agrees to delete its Covid-related social media posts on ivermectin as part of a settlement after three physicians who objected to the agencys mes...